All In Biotech

Drug Trial Radar · NCT06260163

A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis

A Phase 3 Randomized, Open-label Induction, Double-blind Maintenance, Parallel-group, Multicenter Protocol to Evaluate the Efficacy, Safety, and Pharmacokinetics of Guselkumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis

Last checked: Nov 20, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 112 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

112

Actual

Start

Jan 19, 2024

Primary completion

Feb 10, 2027

Study completion Apr 28, 2027

Sponsor

Lead sponsor
Janssen Research & Development, LLCJohnson & Johnson (Janssen) (JNJ)
Sponsor type
Industry
First posted
Feb 15, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 2 years, up to 17 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the efficacy of guselkumab in pediatric participants with moderately to severely active ulcerative colitis at the end of maintenance therapy among participants who were induction responders.

Conditions

  • Colitis, Ulcerative

Interventions

  • Guselkumab SubcutaneousDrug

    Guselkumab will be administered subcutaneously.

  • Guselkumab IntravenousDrug

    Guselkumab will be administered intravenously.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants with Clinical Remission at Week 56Time frame: Week 56

Locations

61 sites in 13 countries. Site status is shown where the registry gives one.

  • Children's Hospital Oakland

    Oakland, California

  • Riley Hospital for Children

    Indianapolis, Indiana

  • NYU Langone Health

    Lake Success, New York

  • The Kids Research Institute Australia on behalf of the Centre for Child Health Research

    Nedlands, Australia

  • Mater Hospital Brisbane Inflammatory Bowel Diseases

    South Brisbane, Australia

  • The Children's Hospital at Westmead

    Westmead, Australia

  • CHU Charleroi Chimay

    Charleroi, Belgium

  • UZ Gent

    Ghent, Belgium

  • UZ Brussel

    Jette, Belgium

  • UZ Leuven

    Leuven, Belgium

  • Capital Center For Children's health Capital Medical University

    Beijing, China

  • Peking University Third Hospital

    Beijing, China

  • Changzhou No 2 Peoples Hospital

    Changzhou, China

  • The Childrens Hospital Zhejiang University School Of Medicine

    Hangzhou, China

  • Sir Run Run Shaw Hospital Zhejiang University School of Medicine

    Hangzhou, China

  • Ruijin Hospital Shanghai Jiao Tong University

    Shanghai, China

  • Shengjing Hospital Of China Medical University

    Shenyang, China

  • Henan Children's Hospital, Zhengzhou Children's Hospital

    Zhengzhou, China

  • Aarhus Universitetshospital

    Aarhus N, Denmark

  • Hvidovre Hospital

    Hvidovre, Denmark

  • Hospices Civils de Lyon - Groupement Hospitalier Est - Hopital Femme Mere Enfant

    Bron, France

  • Hopital Francois Mitterand

    Dijon, France

  • CHRU Lille

    Lille, France

  • APHP Hopital Robert Debre

    Paris, France

  • CHU Toulouse

    Toulouse, France

  • ASST Papa Giovanni XXIII Bergamo

    Bergamo, Italy

  • Azienda USL di Bologna - Ospedale Maggiore

    Bologna, Italy

  • AOU Meyer

    Florence, Italy

  • Ospedale S. Spirito, Azienda Sanitaria Pescara

    Pescara, Italy

  • AOU Policlinico Umberto I

    Roma, Italy

  • IRCCS Ospedale Pediatrico Bambino Gesu

    Roma, Italy

  • Casa Sollievo della Sofferenza

    San Giovanni Rotondo, Italy

  • IRCCS Materno Infantile Burlo Garofolo

    Trieste, Italy

  • Tokyo Metropolitan Children's Medical Center

    Fuchū, Japan

  • Kanazawa University Hospital

    Kanazawa, Japan

  • Kobe University Hospital

    Kobe, Japan

  • Japanese Red Cross Kumamoto Hospital

    Kumamoto, Japan

  • Shinshu University Hospital

    Matsumoto, Japan

  • Saga University Hospital

    Saga, Japan

  • National Center for Child Health and Development

    Setagaya Ku, Japan

Showing 40 of 61 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.